A summarization of the literature on the anticancer effects of quercetin against luminal A-derived breast cancer stem cells includes (i) targeting the ERα receptor, Notch and PI3/AKT/mTOR signaling pathways, (ii) lowering the expression of the multidrug resistance transporter, and (iii) inhibits the nuclear translocation of proteins involved in the breast cancer stemness and self-renewal process. This evidence concerns the gene PI3 and breast carcinoma.